Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Amalgamated Bank

Amalgamated Bank lessened its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 12.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,625 shares of the financial services provider’s stock after selling 1,358 shares during the quarter. Amalgamated Bank’s holdings in Trupanion were worth $404,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its position in shares of Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after buying an additional 596 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Trupanion during the second quarter worth about $162,000. Oppenheimer Asset Management Inc. bought a new position in Trupanion in the second quarter worth about $235,000. Handelsbanken Fonder AB acquired a new position in Trupanion in the third quarter valued at approximately $248,000. Finally, Bayesian Capital Management LP bought a new position in shares of Trupanion during the first quarter valued at approximately $253,000.

Insider Activity

In other news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at $4,647,256.32. This represents a 6.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,124 shares of company stock worth $482,981. 5.50% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

TRUP has been the topic of several recent research reports. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Northland Securities raised their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Bank of America upped their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Piper Sandler lifted their price objective on shares of Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Finally, Stifel Nicolaus boosted their target price on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $44.67.

Trupanion Stock Performance

TRUP stock opened at $52.76 on Friday. The company has a 50-day simple moving average of $48.23 and a 200 day simple moving average of $38.22. The company has a market capitalization of $2.23 billion, a P/E ratio of -164.88 and a beta of 1.69. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The company had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same period in the prior year, the business posted ($0.10) EPS. The business’s revenue for the quarter was up 14.6% compared to the same quarter last year. Sell-side analysts predict that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.